Nanobody-Based Immunosensor Enables Robust POC Testing in Harsh Conditions
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Point-of-Care |
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Molecular Diagnostics, Swabs |
OralDNA Labs acquired Sensible Diagnostics to enhance its rapid point-of-care molecular diagnostic testing capabilities.
Read MorePosted by Chris Wolski | Sep 16, 2024 | Specimen Collection & Handling |
Truvian CEO Jay Srinivasan outlines how the company’s instrument could revolutionize blood testing at the point-of-care.
Read MorePosted by Andy Lundin | Aug 21, 2024 | Covid 19 |
The landscape of respiratory virus testing has evolved rapidly, driven by burgeoning diagnostic solutions like multiplex testing.
Read More